Hot Features
프리미엄
무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV), today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of...
DALLAS, June 30, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Javelin Pharmaceuticals Inc. (AMEX:JAV). The report includes financial, comparative and...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") announces that on June 18, 2010, Business Wire, a news release service, inadvertently issued a hoax press release...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that Hospira, Inc. ("Hospira") funded a $2 million loan to Javelin on June 10, 2010 under the...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that on June 4, 2010, Javelin received notice from Hospira, Inc. ("Hospira") that Hospira will fund...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") announces that on May 28, 2010, Javelin received notice from the staff of the NYSE Amex LLC (the “Exchange”) that...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that it has filed a lawsuit against Hospira, Inc. ("Hospira") and Discus Acquisition Corporation, a...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer of novel acute care pain products, today announced that Therabel Pharma UK Limited ("Therabel"), a subsidiary...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer of novel acute care pain products, commented on the tender offer extension by Hospira, Inc. Hospira...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV - News), a leading developer of novel acute care pain products, today reported its unaudited financial results for the first...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 기호 | 가격 | 볼륨 |
|---|---|---|
| AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 26.9496 (0.00%) | 0 |
| AAPXT Rex 2X Long Apple Daily Target ETF | US$ 31.69 (0.00%) | 0 |
| AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 26.3554 (0.00%) | 0 |
| AAAUGoldman Sachs Physical Gold ETF Shares | US$ 25.705 (0.00%) | 0 |
| AAAAlternative Access First Priority CLO Bond ETF | US$ 25.065 (0.00%) | 0 |
